4583 — Chiome Bioscience Share News
0.000.00%
Last trade - 00:00Table: Chiome Bioscience - Q1 parent results
Table: Chiome Bioscience -2020 parent results
Brief: Chiome To Grant Co Exclusive Right And License To Antibodies Targeting Human Trop2
Table: Chiome Bioscience - 9-MTH parent results
Table: Chiome Bioscience - 6-MTH parent results
Table: Chiome Bioscience - Q1 parent results
Table: Chiome Bioscience -2019 parent results
Table: Chiome Bioscience - 9-MTH parent results
Table: Chiome Bioscience - 6-MTH parent results
Table: Chiome Bioscience - Q1 parent results
Table: Chiome Bioscience -2018 parent results
Table: Chiome Bioscience - 9-MTH parent results
Table: Chiome Bioscience - 6-MTH parent results
Table: Chiome Bioscience - Q1 parent results
Brief: Chiome Bioscience says execution of collaborative development license and exclusive option agreement for anti-Semaphorin 3A antibody
Table: Chiome Bioscience -2017 parent results
Brief: Chiome Bioscience says termination of joint research contract
Brief: Chiome Bioscience to sign joint research agreement with Trans Chromosomics
Table: Chiome Bioscience - 9-MTH parent results